| Quarterly Financials | Jun 2018 | Sept 2018 | Dec 2018 | Mar 2019 | Jun 2019 | Sept 2019 | Dec 2019 | Mar 2020 | Jun 2020 | Sept 2020 | Dec 2020 | Mar 2021 | Jun 2021 | Sept 2021 | Dec 2021 | Mar 2022 | Jun 2022 | Sept 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sept 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sept 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sept 2025 |
Revenue  | 16 | 15 | 12 | 17 | 13 | 14 | 16 | 16 | 7 | 16 | 17 | 19 | 16 | 19 | 20 | 18 | 18 | 19 | 19 | 20 | 23 | 21 | 24 | 22 | 26 | 26 | 26 | 31 | 33 | 31 |
| Expenses | 15 | 14 | 13 | 15 | 13 | 14 | 15 | 15 | 8 | 15 | 16 | 17 | 14 | 18 | 18 | 16 | 15 | 17 | 19 | 20 | 21 | 21 | 25 | 22 | 25 | 26 | 27 | 34 | 32 | 27 |
| EBITDA | 1 | 1 | -1 | 3 | 1 | -0 | 1 | 1 | -1 | 1 | 2 | 2 | 1 | 1 | 2 | 2 | 3 | 2 | -0 | -0 | 2 | 0 | -0 | 1 | 1 | 0 | -1 | -3 | 1 | 3 |
| Operating Profit % | 4 % | 4 % | -7 % | 2 % | 3 % | -2 % | 7 % | 5 % | -12 % | 4 % | 7 % | 2 % | 8 % | 3 % | 8 % | 9 % | 15 % | 8 % | -0 % | -2 % | 6 % | -1 % | -3 % | 0 % | 4 % | -0 % | -4 % | -9 % | 2 % | 10 % |
| Depreciation | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 0 | 0 | 0 | 2 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
| Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 1 | 0 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
| Profit Before Tax | -0 | -0 | -2 | 1 | -1 | -1 | -0 | -0 | -2 | -0 | -0 | 1 | 0 | -0 | 1 | 1 | 2 | 1 | -1 | -2 | 1 | -1 | -1 | -1 | 0 | -1 | -2 | -4 | -1 | 2 |
| Tax | -0 | 0 | 0 | -1 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | 0 | 0 | 0 | -0 | -0 | 0 | 0 | -0 | 0 | 0 | 0 | 0 | -0 | 0 | 0 | 0 | 0 | 0 |
| Net Profit | -0 | -0 | -2 | 2 | -1 | -1 | 0 | -0 | -2 | -0 | 0 | 1 | 0 | -0 | 1 | 1 | 2 | 1 | -1 | -2 | 1 | -1 | -1 | -1 | 0 | -1 | -2 | -4 | -1 | 2 |
| EPS in ₹ | -1.16 | -0.56 | -4.46 | 2.96 | -1.55 | -2.59 | 0.01 | -0.66 | -3.68 | -0.50 | 0.16 | 2.23 | 0.27 | -0.67 | 1.63 | 1.29 | 3.84 | 1.68 | -2.05 | -3.80 | 1.04 | -2.32 | -2.48 | -1.81 | -0.50 | -2.41 | -4.03 | -7.03 | -2.02 | 3.17 |
GKB Ophthalmics
GKB Ophthalmics
48.76
-1.48
(-2.95%)
Market Cap
₹- Cr
PE Ratio
-
Volume
10,046.00
Day High - Low
₹52.38 - ₹47.26
52W High-Low
₹112.45 - ₹49.15
Key Fundamentals
Market Cap
- Cr
EPS
-
PB Ratio
-
Book Value
104.27
EBITDA
-
Dividend Yield
- %
Industry
Healthcare Sector
Medical Equipment ROE Growth %
-
Debt to Equity
-
Actual
Company News
View All News
GKB Ophthalmics Shareholders Approve Voluntary Winding Up of Material Subsidiary GSV Ophthalmics
8 days ago
8 days agoGKB Ophthalmics Limited shareholders passed resolutions through postal ballot on November 1, 2025, approving the voluntary winding up of material subsidiary GSV Ophthalmics Private Limited and related party transactions worth Rs. 15 crores. The subsidiary, which holds the company's Rs. 11.70 crores investment, never commenced operations since inception due to COVID-19 disruptions making the project financially unviable, with proceeds to be used for general corporate purposes.
GSV Ophthalmics Private Limited, a material subsidiary of GKB Ophthalmics Ltd., has approved voluntary liquidation under the Insolvency and Bankruptcy Code through a special resolution passed at an extraordinary general meeting. The subsidiary has appointed Manoj G. Nair as the liquidator to carry out the voluntary liquidation process, following earlier approvals from the subsidiary's board and the holding company's shareholders.
GKB Ophthalmics Reports Consolidated Profit of Rs 58.21 Lakhs Despite Standalone Loss in H1 FY2026Nov 14, 2025
GKB Ophthalmics Limited posted a consolidated profit of Rs 58.21 lakhs for the half-year ended September 30, 2025, while reporting a standalone loss of Rs 266.72 lakhs for the same period. The company's Board approved voluntary winding up of its material subsidiary GSV Ophthalmics Private Limited, which was not carrying any business since inception.
View more
Peer Comparison Compare Peers on Screener
Competitors | LTP | Market Cap (₹ Cr.) | P/E Ratio | Revenue (₹ Cr.) | YoY Revenue Growth % | Net Profit (₹ Cr.) | YoY Profit Growth % | RSI |
|---|---|---|---|---|---|---|---|---|
234.82 | - | #1 - | - | - | - | - | 54.03 | |
725.00 | - | #1 - | - | - | - | - | 53.11 | |
599.00 | - | #1 - | - | - | - | - | 50.63 | |
275.50 | - | #1 - | - | - | - | - | 40.49 | |
227.89 | - | #1 - | - | - | - | - | 35.97 | |
1,910.80 | - | #1 - | - | - | - | - | 47.71 | |
275.00 | - | #1 - | - | - | - | - | 50.31 | |
318.55 | - | #1 - | - | - | - | - | 54.03 | |
20.75 | - | #1 - | - | - | - | - | 42.20 | |
305.65 | - | #1 - | - | - | - | - | 66.81 |
Growth Rate
Revenue Growth
-
Net Income Growth
-
Cash Flow Change
-
ROE
-
ROCE
-
EBITDA Margin (Avg.)
-
Quarterly Financial Results
Balance Sheet
| Balance Sheet | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
| Total Assets | 75 | 69 | 82 | 83 | 93 | 102 | 107 | 110 | 112 | 115 | 125 |
| Fixed Assets | 12 | 13 | 18 | 18 | 26 | 26 | 24 | 23 | 19 | 18 | 17 |
| Current Assets | 46 | 51 | 63 | 64 | 64 | 73 | 74 | 76 | 84 | 88 | 99 |
| Capital Work in Progress | 1 | 1 | 1 | 0 | 0 | 0 | 1 | 3 | 4 | 4 | 4 |
| Investments | 0 | 6 | 4 | 0 | 1 | 1 | 2 | 2 | 2 | 2 | 2 |
| Other Assets | 63 | 50 | 60 | 64 | 67 | 75 | 80 | 82 | 87 | 91 | 102 |
| Total Liabilities | 75 | 69 | 82 | 83 | 93 | 102 | 107 | 110 | 112 | 115 | 125 |
| Current Liabilities | 33 | 23 | 33 | 36 | 37 | 41 | 38 | 39 | 41 | 46 | 62 |
| Non Current Liabilities | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 4 | 4 | 4 | 6 |
| Total Equity | 40 | 45 | 47 | 45 | 55 | 59 | 66 | 67 | 67 | 64 | 56 |
| Reserve & Surplus | 36 | 41 | 43 | 41 | 47 | 54 | 58 | 58 | 58 | 55 | 47 |
| Share Capital | 4 | 4 | 4 | 4 | 5 | 5 | 5 | 5 | 5 | 5 | 5 |
Cash Flow
| Cash Flow | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
| Net Cash Flow | 1 | 0 | -1 | 0 | 7 | 4 | -7 | -0 | -4 | 1 | -0 |
| Investing Activities | -1 | 15 | 4 | 1 | -10 | -4 | -17 | -4 | 1 | -2 | 3 |
| Operating Activities | 7 | -11 | -3 | -3 | 4 | 3 | 7 | 5 | -3 | 4 | -3 |
| Financing Activities | -6 | -3 | -1 | 1 | 13 | 4 | 3 | -2 | -2 | -2 | 1 |
Share Holding
| % Holding | Mar 2021 | Jun 2021 | Sept 2021 | Dec 2021 | Mar 2022 | Jun 2022 | Sept 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sept 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sept 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sept 2025 |
| Promoter | 59.44 % | 59.24 % | 59.58 % | 59.69 % | 59.72 % | 59.73 % | 59.16 % | 59.09 % | 59.09 % | 59.18 % | 50.86 % | 50.88 % | 50.93 % | 50.95 % | 50.95 % | 50.98 % | 50.99 % | 51.06 % | 51.06 % |
| FIIs | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 1.79 % | 1.79 % | 1.79 % | 1.79 % | 1.79 % | 1.79 % | 1.79 % | 1.79 % | 1.79 % |
| DIIs | 0.39 % | 0.39 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.01 % | 0.01 % | 0.01 % | 0.01 % | 0.01 % | 0.01 % | 0.01 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % |
| Government | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % |
| Public / Retail | 23.93 % | 24.44 % | 24.90 % | 24.48 % | 24.63 % | 24.79 % | 24.82 % | 24.79 % | 27.11 % | 27.40 % | 36.01 % | 36.04 % | 36.04 % | 36.64 % | 36.34 % | 36.96 % | 37.36 % | 37.22 % | 37.23 % |
| Others | 16.24 % | 15.93 % | 15.52 % | 15.83 % | 15.65 % | 15.47 % | 16.01 % | 16.11 % | 13.79 % | 13.41 % | 11.34 % | 11.28 % | 11.23 % | 10.63 % | 10.93 % | 10.27 % | 9.87 % | 9.94 % | 9.93 % |
| No of Share Holders | 1,185 | 1,545 | 1,430 | 1,434 | 1,432 | 1,443 | 1,443 | 1,637 | 1,933 | 2,030 | 2,115 | 2,233 | 2,370 | 2,690 | 2,510 | 2,539 | 2,538 | 2,550 | 2,601 |
Corporate Action
| Record Date | Corporate Action | Information | Announcement Day | LTP at Annoucement | LTP at Record Day |
|---|---|---|---|---|---|
| 20 Aug 2024 |  Annual General Meeting | NA | 20 Aug 2024 | 87.04 | 108.60 |
| 14 Nov 2024 |  Quarterly Result Announcement | NA | 14 Nov 2024 | 100.80 | 99.65 |
| 13 Feb 2025 | Quarterly Result Announcement | NA | 13 Feb 2025 | 90.18 | 89.12 |
| 30 May 2025 | Quarterly Result Announcement | NA | 30 May 2025 | 69.80 | 73.00 |
| 14 Aug 2025 | Quarterly Result Announcement | NA | 14 Aug 2025 | 76.35 | 74.99 |
| 21 Aug 2025 | Annual General Meeting | NA | 21 Aug 2025 | 73.00 | 79.91 |
| 14 Nov 2025 | Quarterly Result Announcement | NA | 14 Nov 2025 | 68.94 | 61.03 |
Announcements
GKB Ophthalmics Limited - Minutes Of Postal Ballot8 days ago
8 days agoIntimation Under Regulation 30 Of SEBI(LODR) Regulation 2015-Approval Of Voluntary Liquidation Of Material Subsidiary GSV Ophthalmics Private LimitedNov 21, 2025
Nov 21, 2025Intimation Under Regulation 30 Of SEBI (LODR) Regulations 2015- Voluntary Winding Up Of Material Subsidiary.
Nov 20, 2025
Nov 20, 2025Announcement under Regulation 30 (LODR)-Newspaper PublicationNov 19, 2025
Nov 19, 2025Unaudited Financial Results For The Quarter And Half Year Ended September 30 2025.Nov 14, 2025
Nov 14, 2025Board Meeting Outcome for Outcome Of The Board Meeting Of GKB Ophthalmics Limited Held On November 14 2025 And Signing Of Loan AgreementNov 14, 2025
Nov 14, 2025Shareholder Meeting / Postal Ballot-Outcome of Postal_BallotNov 03, 2025
Nov 03, 2025 Shareholder Meeting / Postal Ballot-Scrutinizer"s ReportNov 03, 2025
Nov 03, 2025Board Meeting Intimation for Approval Of Unaudited Financial Results For The Quarter And Half Year Ended September 302025Oct 28, 2025
Oct 28, 2025Intimation Of Reduction In Production And Manpower At The Companys Plant Situated At Tivim Industrial EstateGoa.Oct 11, 2025
Oct 11, 2025Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Oct 06, 2025
Oct 06, 2025Announcement under Regulation 30 (LODR)-Newspaper PublicationOct 03, 2025
Oct 03, 2025Shareholder Meeting / Postal Ballot-Notice of Postal BallotSep 30, 2025
Sep 30, 2025Closure of Trading WindowSep 27, 2025
Sep 27, 2025Intimation And Board Outcome Regarding Voluntary Liquidation Of Material Subsidiary - GSV Ophthalmics Private Limited - September 22 2025.Sep 22, 2025
Sep 22, 2025Closure of Trading WindowSep 17, 2025
Sep 17, 2025Submission Of Minutes Of 43Rd Annual General Meeting Of The Company Held On 21St August 2025Sep 16, 2025
Sep 16, 2025Receipt Of Order - Update On Case No. 32/09 Filed For Adjudication Of Charter Of DemandsSep 12, 2025
Sep 12, 2025Scrutinizers Report - Voting Results Of Annual General Meeting Held On August 21 2025.Aug 22, 2025
Aug 22, 2025Shareholder Meeting / Postal Ballot-Outcome of AGMAug 21, 2025
Aug 21, 2025Announcement under Regulation 30 (LODR)-Newspaper PublicationAug 19, 2025
Aug 19, 2025Corrigendum To The Annual Report For The Financial Year 2024-2025.Aug 16, 2025
Aug 16, 2025GKB Ophthalmics Limited - Unaudited Standalone & Consolidated Financial Results - June 30 2025Aug 14, 2025
Aug 14, 2025Board Meeting Outcome for Outcome Of Board Meeting Of GKB Ophthalmics Limited Held On August 14 2025Aug 14, 2025
Aug 14, 2025Board Meeting Intimation for Board Meeting For Approval Of Unaudited Financial Results For The Quarter Ended June 30 2025.Jul 31, 2025
Jul 31, 2025Announcement under Regulation 30 (LODR)-Newspaper PublicationJul 30, 2025
Jul 30, 2025Reg. 34 (1) Annual Report.Jul 29, 2025
Jul 29, 2025Notice For Book ClosureJul 28, 2025
Jul 28, 2025GKB Ophthalmics Limited- Submission Of Annual Report For The Financial Year 2024-25Jul 28, 2025
Jul 28, 2025Announcement under Regulation 30 (LODR)-Newspaper PublicationJul 16, 2025
Jul 16, 2025Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Jul 10, 2025
Jul 10, 2025Board Meeting Outcome for Disclosure Under Regulation 30 SEBI (LODR) Regulations 2015 - Outcome Of Board Meeting Of The Company Held On July 09 2025Jul 09, 2025
Jul 09, 2025Announcement under Regulation 30 (LODR)-Code of Conduct under SEBI (PIT) Regulations 2015Jun 30, 2025
Jun 30, 2025Closure of Trading WindowJun 27, 2025
Jun 27, 2025Announcement under Regulation 30 (LODR)-Newspaper PublicationJun 02, 2025
Jun 02, 2025GKB- Audited Standalone And Consolidated Financial Results For The Quarter And Year Ended March 31 2025May 30, 2025
May 30, 2025Compliances-Reg.24(A)-Annual Secretarial ComplianceMay 30, 2025
May 30, 2025Board Meeting Outcome for Outcome Of The Board Meeting Held On May 30 2025May 30, 2025
May 30, 2025Board Meeting Intimation for Approval Of Audited Standalone And Consolidated Financial Results For The Quarter And Year Ended March 31 2025May 14, 2025
May 14, 2025Intimation Of Change In Contact Details Of Registrar And Share Transfer Agent ("RTA") Of The CompanyApr 21, 2025
Apr 21, 2025Non Applicability Of Circular No. SEBI/HO/DDHS/CIR/P/2018/144 Dated November 26 2018.Apr 10, 2025
Apr 10, 2025Announcement under Regulation 30 (LODR)-Credit RatingApr 09, 2025
Apr 09, 2025Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Apr 08, 2025
Apr 08, 2025Disclosure Under Regulations 31 (4) Of SEBI (Substantial Acquisition Of Shares And Takeover) Regulations 2011 For The Financial Year Ended On March 31 2025.Apr 02, 2025
Apr 02, 2025Intimation Under Regulation 30 Of SEBI( Listing Obligations And Disclosure Requirements) Regulation 2015- Completion Of Tenure Of Independent Director And Re- Constitution Of Committees Of The Board.Mar 31, 2025
Mar 31, 2025Announcement under Regulation 30 (LODR)-Code of Conduct under SEBI (PIT) Regulations 2015Mar 31, 2025
Mar 31, 2025Closure of Trading WindowMar 29, 2025
Mar 29, 2025Outcome Of Independent Directors Meeting Held On March 27 2025.Mar 27, 2025
Mar 27, 2025Notice Of The Independent Directors MeetingMar 18, 2025
Mar 18, 2025Announcement under Regulation 30 (LODR)-Newspaper PublicationFeb 19, 2025
Feb 19, 2025Technical Indicators
we are part of Raise Financial Services
built with love
for indians who love to invest & trade
Market Community
Follow us on
